ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

FDA’s Jane Henney

February 11, 1994

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

Advisory Council To Be Named For Alternative Medicine Cuts

May 27, 1994

Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase

February 27, 2004

Letter In Response To Hadley; RFA Available

July 7, 1995

NCI-Approved Clinical Trials

June 30, 2006